More Business Wire
View Older Stories View Newer Stories-
Swimply Expands Beyond Summertime Pools, Launches “Igloos” for Fall and Winter Experiences
-
ReposiTrak to Host Informative Webinar for Produce Suppliers About Food Traceability
-
Intruder’s 2025 Exposure Management Index: SMBs Face Rising Risk as AI Weaponizes Older CVEs
-
Greenflash Launches Energy-Ready Infrastructure for Data Center Growth in Texas
-
Mueller Industries, Inc. Reports Third Quarter 2025 Earnings
-
Iambic Announces Research Collaboration with Jazz Pharmaceuticals for IAM1363 and Zanidatamab Combination Cohort in HER2-Positive Breast Cancer
-
ConcertAI Appoints Dr. Shaalan Beg as Chief Medical Officer, Oncology
-
ActiveCampaign Opens AI Access to All: Active Intelligence Now Available to All Customers With New Agents and Remote MCP
-
GondolaBio Receives U.S. FDA Orphan Drug and Fast Track Designations for PORT-77 for the Treatment of Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLP)
-
ACI Worldwide and Prosa Redefine Payments in Latin America with Groundbreaking Infrastructure Upgrade
-
Philip Morris International Reports 2025 Third-Quarter & First Nine-Months Results
-
Navan Announces Launch of Initial Public Offering Roadshow
-
Coca-Cola Reports Third Quarter 2025 Results
-
Ryder Secures 2025 Quest for Quality Honor for Value-Added Warehousing & Distribution
-
Pentair Announces Appointments to Executive Leadership Team
-
Pentair Reports Strong Third Quarter 2025 Results
-
SITE Centers Announces Special Common Stock Distribution
-
Blackstone Secured Lending Announces Third Quarter 2025 Earnings Release and Conference Call
-
Halliburton Announces Third Quarter 2025 Results
-
Systematic Review of 15 Studies Focused on Epidemiology and Antimicrobial Resistance of Pneumococcal Serotypes Covered by CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in U.S. Adults
-
Global Indemnity Group, LLC Announces Transfer to Nasdaq Stock Exchange
-
Community Financial System, Inc. Reports Third Quarter 2025 Results
-
Pediatrix Medical Group 2025 Third Quarter Conference Call/Webcast Scheduled for Monday, November 3, 2025
-
GM Financial Reports Third Quarter 2025 Operating Results
-
Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings
-
PulteGroup Reports Third Quarter 2025 Financial Results
-
BlackRock Survey: Opportunity Amid Uncertainty – Insurers Globally Embracing A More Flexible Approach
-
CenterPoint Energy announces sale of its Ohio Natural Gas Business to National Fuel Gas Company for $2.62 billion
-
Henry Schein to Webcast Third Quarter 2025 Conference Call on Tuesday, November 4, 2025, at 8:00 A.M. ET
-
AHF: 80 Organizations Denounce Gilead on Price Hikes Gutting ADAP
-
Amer Sports, Inc. to Report Third Quarter 2025 Financial Results on November 18, 2025
-
Alarm.com to Announce 2025 Third Quarter Results on November 6, 2025
-
Euna Solutions Joins Workday Partner Program
-
Elevance Health Reports Third Quarter 2025 Results
-
Monroe Capital Supports Growth of Anderson Global
-
Jumio Achieves ISO/IEC 30107-3 Level 2 Compliance
-
IFF and BASF Announce Strategic Collaboration to Drive Next-Generation Enzyme and Polymer Innovation
-
Electron to Acquire Rhythmos.io to Help Utilities Expand Grid Capacity Affordably
-
Organigram Global Announces Update to CEO Succession Plan
-
Innovative Industrial Properties Announces Third Quarter 2025 Earnings Release Date and Conference Call
-
Walker & Dunlop Arranges $40 Million Debt and Equity for Seniors Property in Maryland
-
Realize Fund I Secures Record $25M Concordia Investment
-
Xobee Networks Partners with Tidal Communications
-
Cyware Announces Strategic Partnership to Power Advanced Threat Intelligence Operations for Enterprise and Public Sector Security Teams
-
New Sisense Research Uncovers the ‘Churn Paradox’: 86% of Developers Say They’re Happy with Their Analytics Tools, Yet 82% Have Switched
-
Samsara Earns ISO 42001 Certification, Reinforces Commitment to Responsible AI
-
Zilch Partners With Plaid to Enable Open Banking Repayments
-
REPEAT/StratifAI Joins With MSK iHub Challenge Cohort to Advance Validation of Polaris™ Through Access to World-Class Clinical Datasets
-
Atom Therapeutics to Present Positive Data from Clinical Trials of Its Lead Novel Oral Drugs for Chronic Gout and Acute Gout Flares at ACR Convergence 2025
-
Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule
